Sequence variation in NPC1L1 and association with improved LDL-cholesterol lowering in response to ezetimibe treatment
Genomics, pp. 648-656, 2005.
Target of ezetimibeNPC1L1Drug responseGenetic associationClinical trialMore(1+)
Niemann-Pick C1-like 1 (NPC1L1) is an intestinal cholesterol transporter and the molecular target of ezetimibe, a cholesterol absorption inhibitor demonstrated to reduce LDL-cholesterol (LDL-C) both as monotherapy and when co-administered with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins). Interestingly, significant...More
Full Text (Upload PDF)
PPT (Upload PPT)